Department of Surgical Oncology, Leiden University Medical Center, the Netherlands.
Department of Surgical Oncology, Leiden University Medical Center, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Eur J Surg Oncol. 2019 Aug;45(8):1396-1402. doi: 10.1016/j.ejso.2019.03.041. Epub 2019 Apr 9.
Decreased cancer specific survival in older colorectal patients is mainly due to mortality in the first year, emphasizing the importance of the first postoperative year. This study aims to gain an overview and time trends of short-term mortality in octogenarians (≥80 years) with colorectal cancer across four North European countries.
Patients of 80 years or older, operated for colorectal cancer (stage I-III) between 2005 and 2014, were included. Population-based cohorts from Belgium, Denmark, the Netherlands, and Sweden were collected. Separately for colon- and rectal cancer, 30-day, 90-day, one-year, and excess one-year mortality were calculated. Also, short-term mortality over three time periods (2005-2008, 2009-2011, 2012-2014) was analyzed.
In total, 35,158 colon cancer patients and 10,144 rectal cancer patients were included. For colon cancer, 90-day mortality rate was highest in Denmark (15%) and lowest in Sweden (8%). For rectal cancer, 90-day mortality rate was highest in Belgium (11%) and lowest in Sweden (7%). One-year excess mortality rate of colon cancer patients decreased from 2005 to 2008 to 2012-2014 for all countries (Belgium: 17%-11%, Denmark: 21%-15%, the Netherlands: 18%-10%, and Sweden: 10%-8%). For rectal cancer, from 2005 to 2008 to 2012-2014 one-year excess mortality rate decreased in the Netherlands from 16% to 7% and Sweden: 8%-2%).
Short-term mortality rates were high in octogenarians operated for colorectal cancer. Short-term mortality rates differ across four North European countries, but decreased over time for both colon and rectal cancer patients in all countries.
老年结直肠癌患者的癌症特异性生存率降低主要归因于术后第一年的死亡率,这凸显了术后第一年的重要性。本研究旨在概述并分析北欧四国 80 岁以上结直肠癌患者的短期死亡率及其时间趋势。
纳入年龄在 80 岁及以上、于 2005 至 2014 年间接受结直肠癌手术(I-III 期)的患者。本研究收集了来自比利时、丹麦、荷兰和瑞典的基于人群的队列。分别针对结肠癌和直肠癌,计算了 30 天、90 天、1 年和超 1 年的死亡率,还分析了三个时间段(2005-2008 年、2009-2011 年、2012-2014 年)的短期死亡率。
共纳入 35158 例结肠癌患者和 10144 例直肠癌患者。对于结肠癌,90 天死亡率最高的是丹麦(15%),最低的是瑞典(8%)。对于直肠癌,90 天死亡率最高的是比利时(11%),最低的是瑞典(7%)。所有国家的结肠癌患者的 1 年超额死亡率均从 2005 年至 2008 年下降至 2012-2014 年(比利时:17%-11%,丹麦:21%-15%,荷兰:18%-10%,瑞典:10%-8%)。对于直肠癌,2005 年至 2008 年至 2012-2014 年,荷兰的 1 年超额死亡率从 16%降至 7%,瑞典从 8%降至 2%。
接受结直肠癌手术的 80 岁以上老年患者的短期死亡率较高。北欧四国的短期死亡率存在差异,但所有国家的结肠癌和直肠癌患者的短期死亡率均随时间推移而降低。